However, for T2DM patients receiving standard blood glucose regimen, the final overall HbA1c level remain above 7.0% according to the Chinese guidelines for diabetes prevention and treatment and the clinical practice by using metformin, sulfonylureas (except glycolide), insulin and other conventional hypoglycemic drugs. The gene discussed is INS; the disease is diabetes mellitus.